Each year CBNS hosts a prominent overseas professor to Australia to promote bio-nano science and to give presentations at our nodes. The CBNS international visiting professor is a plenary speaker at the International Nanomedicine Conference in Sydney. This annual event is co-hosted by the CBNS and the Australian Centre for Nanomedicine.
The visiting international professor participates as a member of the CBNS Scientific Advisory Board (SAB). Each year the visiting professor brings his or her varied and unique expertise to the SAB, which meets during the Nanomedicine Conference.
In addition to our international Visiting Professor, we established an Australian Visiting Professor Program in 2021. The Australian Visiting Professor joined our members at the CBNS Final Annual Research Workshop in March 2021.
Professor Louise Emmett is the Director of Theranostics and Nuclear medicine at St Vincent’s Hospital Sydney. She has been instrumental in developing the radiopharmacy initiative on the St Vincent’s Campus and has introduced multiple new radioisotopes for clinical and research purposes. The St Vincent’s Theranostics Department is highly published in both PET imaging and radionuclide therapy. She is heavily involved in multi-site multidisciplinary trials run across Australia, in addition to undertaking early phase clinical trials on the St Vincent’s Campus. She believes in the power of clinical research to optimise treatments and improve lives.
Dr David Tai Leong is currently an Associate Professor at the Department of Chemical and Biomolecular Engineering, National University of Singapore (NUS). He obtained his Bachelor in Chemical Engineering and his PhD in biology from NUS and was trained in Howard Hughes Medical Institute at the University of Pennsylvania as a postdoc fellow under Professor Morris Birnbaum. He was a recipient of the prestigious Lee Kuan Yew Fellowship and was elected as a Fellow of the Royal Society of Chemistry. His research interests lie in the fundamental understanding of the biological effects of nanomaterials and their applications in healthcare.
Dr Leong was unable to visit us in person during 2020 but we were fortunate to have him provide CBNS with a webinar on 28 July 2020.
Professor Chen received her Bachelor’s degree in chemistry (1991) and obtained her PhD degree in Biomedical Engineering (1996) from Huazhong University of Science and Technology of China. She worked as a postdoctoral research fellow at the Key Laboratory of Nuclear Analytical Techniques, Institute of High Energy Physics of Chinese Academy of Sciences (1996-1998) and at the Medical Nobel Institute for Biochemistry of Karolinska Institute, Sweden (2001-2002). From 2002 onwards, she has been working as a group and project leader at the China Nanosafety lab. Professor Chen has been awarded the National Award for Innovation and Outstanding Service to the Standard authorised by Standardization Administration of the People’s Republic of China in 2011, the Second Prize of Beijing Science and Technology (ranked second) in 2008, the Second Prize of the National Natural Science Award (ranked second) in 2012. During her 2 visits to Australia, Professor Chen visited the following labs and gave the following talks:
Professor Chan is currently a Distinguished Professor in the Institute of Biomaterials and Biomedical Engineering at the University of Toronto. Professor Chan received his B.S. degree from the University of Illinois in 1996, PhD degree from Indiana University in 2001, and post-doctoral training at the University of California (San Diego). He moved to Toronto in 2002 to lead the Integrated Nanotechnology/Biomedical Sciences Laboratory. His research interest is in the development and translation of nanotechnology for diagnosing and treating cancer and infectious diseases. He has received NSERC E. W. R. Memorial Steacie Fellowship, Kabiller Young Investigator Award in Nanomedicine, the BF Goodrich Young Inventors Award, Lord Rank Prize Fund award in Optoelectronics (England), and Dennis Gabor Award (Hungary). He is currently an Associate Editor of ACS Nano. Finally, he is also affiliated with a number of different departments at the University of Toronto: Department of Materials Science and Engineering, the Terrence Donnelly Center for Cellular and Biomolecular Research Chemistry, Chemistry and Chemical Engineering.
During his visit to Australia, Professor Chan visited the following labs and gave the following talks:
Professor Wolfgang Parak is the Professor of Experimental Physics at the Philipps-University of Marburg, Germany and head of the Biofunctional Nanomaterials Unit at CIC biomaGUNE, San Sebastian, Spain, He has significantly contributed to the development of new surface chemistries of inorganic nanoparticles and towards the characterization of their physicochemical properties. In particular, the development of an amphiphilic polymer coating is nowadays used by many different groups worldwide.
During his visit to Australia, Professor Parak visited labs and gave talks:
Professor Vince Rotello is the Charles A. Goessmann Professor of Chemistry Professor of Chemistry at UMass Amherst. His research program focuses on using synthetic organic chemistry to engineer the interface between hard and soft materials and spans the areas of devices, polymers, and nanotechnology/bionanotechnology, with over 460 peer-reviewed papers published to date. He is actively involved in the development of new nanomanufacturing methods and in the area of bionanotechnology.
His research includes programs in delivery, imaging, diagnostics and nanotoxicology.
During his visit to Australia Professor Rotello visited labs and gave seminars:
Professor Leaf Huang is a biophysicist at the Eshelman School of Pharmacy at the University of North Carolina. Work in his Laboratory of Drug Targeting focuses on liposomes and immunoliposomes for drug delivery, with current research in siRNA therapy, and receptor mediated drug and vaccine targeting using self-assembled nanoparticles.
During his visit to Australia Professor Huang visited labs and gave seminars:
2014’s Visiting Professor, Mark E. Davis from Caltech, was co-hosted with the Australian Centre for Nanomedicine.
Professor Davis is actively involved in the creation, development and translation of nanoparticle delivery systems for gene silencing and drug delivery in humans. He is the senior author of a Nature paper describing the first example of RNA interference in humans as part of a first-in-human clinical trial of siRNA delivery via targeted nanoparticles for cancer (Nature 2010, 464, 1067).
During his visit to Australia Professor Davis visited labs and gave seminars: